Austria vs Dominican Republic: The number of people with susceptibility test result for rifampicin
Austria
86.84
in 2021
Dominican Republic
87.56
in 2021
Austria rank
80th
Dominican Republic rank
78th
The number of people with susceptibility test result for rifampicin over time
- Austria
- Dominican Republic
How they compare
Dominican Republic currently reports 87.56 against 86.84 in Austria, a difference of 0.72.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Austria ahead.
Austria ranks 80th and Dominican Republic ranks 78th of 146 countries.
Austria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Austria | Dominican Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.78 | 27.86 | 60.92 | Austria |
| 2020s | 86.89 | 79.91 | 6.98 | Austria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Austria or Dominican Republic?
- Dominican Republic, at 87.56 against 86.84 in Austria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Austria and Dominican Republic?
- 0.72, with Dominican Republic ahead.
- How many years of comparable data are there for Austria and Dominican Republic?
- 5 years are reported by both, from 2017 to 2021.
- How do Austria and Dominican Republic rank globally for the number of people with susceptibility test result for rifampicin?
- Austria ranks 80th and Dominican Republic ranks 78th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.